BioHarvest SciencesBHST +1.96%63 PS Ratio is 1.60 as of Jul. 01, 2026, which is 80% below its 10-year median of 8.17. GuruFocus rates BHST with a GF Score™ of 63/100 and a GF Value™ of $8.57 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,933 Consumer Packaged Goods companies, BioHarvest Sciences ranks worse than 69.79% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, BioHarvest Sciences's share price is $2.89.
BioHarvest Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $1.81. Hence, BioHarvest Sciences's PS Ratio for today is 1.60.
Good Sign:
BioHarvest Sciences Inc stock PS Ratio (=1.6) is close to 10-year low of 1.53.
The historical rank and industry rank for BioHarvest Sciences's PS Ratio or its related term are showing as below:
BHST'
s PS Ratio Range Over the Past 10 Years
Min: 1.53 Med: 8.17 Max: 1096.37
Current: 1.6
During the past 12 years, BioHarvest Sciences's highest PS Ratio was 1096.37. The lowest was 1.53. And the median was 8.17.
BHST's PS Ratio is ranked worse than 69.79% of 1933
companies
in the Consumer Packaged Goods industry
Industry Median: 0.85
vs BHST: 1.60
BioHarvest Sciences Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of BioHarvest Sciences was 11.70% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 64.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 113.60% per year.
During the past 12 years, BioHarvest Sciences's highest 3-Year average Revenue per Share Growth Rate was 183.70% per year. The lowest was 64.50% per year. And the median was 109.50% per year.
Back to Basics: PS Ratio
BioHarvest Sciences (NAS:BHST) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
BioHarvest Sciences PS Ratio Related Terms
BioHarvest Sciences PS Ratio Historical Data
* Premium members only.
The historical data trend for BioHarvest Sciences's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, BioHarvest Sciences's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BioHarvest Sciences PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, BioHarvest Sciences's PS Ratio distribution charts can be found below:
* The bar in red indicates where BioHarvest Sciences's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
BioHarvest Sciences's Share Price of today is $2.89. BioHarvest Sciences's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.81.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
BioHarvest Sciences (BHST) has a PS Ratio of 1.60 as of Jul. 01, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on BioHarvest Sciences and its competitors. This is 80% below median its historical median of 8.17. Over the past decade, BioHarvest Sciences' PS Ratio has ranged from 1.53 to 1,096.37. According to the industry distribution chart, BioHarvest Sciences ranks #1349 out of 1933 companies in the Consumer Packaged Goods industry, placing it in the top 69.8%.
Is BioHarvest Sciences' PS Ratio too high?
BioHarvest Sciences' current PS Ratio of 1.60 is 80% below median its 10-year median of 8.17. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 1,096.37. The Consumer Packaged Goods industry median PS Ratio is 0.85. BioHarvest Sciences' value of 1.60 is 88.2% above this industry median. Based on the distribution chart, BioHarvest Sciences ranks #1349 out of 1933 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, BioHarvest Sciences has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioHarvest Sciences' PS Ratio compare to BRID and BOF?
According to the Consumer Packaged Goods industry distribution chart, BioHarvest Sciences ranks #1349 out of 1933 companies for PS Ratio. This places BioHarvest Sciences in the lower half of its industry. The industry median PS Ratio is 0.85. BioHarvest Sciences' value of 1.60 is 88.2% above this benchmark. Historically, BioHarvest Sciences' own PS Ratio has ranged from 1.53 to 1,096.37 over the past decade. While the company's 10-year median is 8.17 vs. the industry median of 0.85, BioHarvest Sciences has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.85, based on 1,933 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. BioHarvest Sciences's current PS Ratio of 1.60 is 88.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on BioHarvest Sciences and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BioHarvest Sciences's current PS Ratio is 1.60, which is 80% below median its own 10-year median of 8.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioHarvest Sciences stock overvalued right now?
Based on GuruFocus' analysis, BioHarvest Sciences (BHST) is currently considered Possible Value Trap. The stock's GF Value™ is $8.57, compared to a current price of $2.89 — trading 66.3% below its estimated fair value. The current PS Ratio is 1.60, which is 80% below median its 10-year median of 8.17 and 88.2% above the Consumer Packaged Goods industry median of 0.85. BioHarvest Sciences' overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For BioHarvest Sciences (BHST), the current PS Ratio is 1.60 as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is BioHarvest Sciences (BHST) Overvalued in 2026?
Based on GuruFocus' analysis, BioHarvest Sciences stock appears to be undervalued.
The current stock price of $2.89 is trading 66.3% below its estimated GF Value™ of $8.57.
GuruFocus considers BioHarvest Sciences to be Possible Value Trap.
Key valuation signals for BHST:
PS Ratio: 1.60 (80% below median its 10-year median of 8.17)
GF Value™: $8.57 vs. price of $2.89 (66.3% below fair value)
Industry Position: 88.2% above the Consumer Packaged Goods median (#1349 of 1933)
No single metric tells the full story. See the BHST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. The Company has two operating segments or business units: the Products business unit and the CDMO Services business unit. In identifying these operating segments, management generally follows the Company's service lines representing its main products and services. The Products Business Unit - Nutraceuticals: Research, development, manufacturing, marketing and sales of science-based health and wellness nutraceutical solutions which are manufactured and sold as dietary supplements, functional food and beverages. The CDMO Services Business Unit - comprising a Contract Development and Manufacturing Operation that offers pharmaceuticals, cosmeceuticals, nutraceuticals, and nutritions.
63GF Score
Get the complete analysis for BHST
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BHST has been successfully added to your 
